Endocrinology, Vol 111, 118-124, Copyright © 1982 by Endocrine Society

ARTICLES

Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism

AH Tashjian Jr, EL Hohmann, HN Antoniades and L Levine

Platelet-derived growth factor (PDGF) stimulated up to 15-fold the production of prostaglandin E2 (PGE2) and bone resorption in neonatal mouse calvaria in organ culture. The action of PDGF on bone resorption occurred at low concentrations of the protein (ED50 = 10 ng/ml). All concentrations of PDGF which stimulated resorption also enhanced the production of PGE2 by bone; concentrations of PDGF which did not stimulate resorption did not enhance PGE2 production. PDGF-induced formation of PGE2 and bone resorption were inhibited completely by indomethacin (100 ng/ml) and hydrocortisone (1 microgram/ml). Indomethacin did not inhibit the bone resorption-stimulating activity of exogenous PGE2. In the continued presence of a maximum concentration of PDGF (100 ng/ml), an increase in bone resorption, as measured by an increase in medium calcium, was detected at 16 h (P less than 0.01), but not at 12 h; however, an increase in PGE2 production occurred within the first 2 h of treatment. A similar lag period for the onset of bone resorption was seen after the addition of exogenous PGE2 to the culture medium. On the other hand, exposure of bones to PDGF (50 ng/ml) for as brief a period as 5-15 min, followed by washout of PDGF, triggered bone resorption over the subsequent 48 h. PDGF increased cAMP production by bone within 30 min, and this effect of PDGF was blocked completely by indomethacin while the action of exogenous PGE2 on the production of cAMP was not blocked by indomethacin. The action of a low concentration of PDGF (1 ng/ml), which did not stimulate bone resorption alone, was potentiated by the phosphodiesterase inhibitor isobutylmethylxanthine (4 microM). We conclude that low concentrations of PDGF stimulate bone resorption via the enhanced local production of PGE2.

This article has been cited by other articles:

				B. A. Watkins, Y. Li, and M. F. Seifert Nutraceutical Fatty Acids as Biochemical and Molecular Modulators of Skeletal Biology J. Am. Coll. Nutr., October 1, 2001; 20(90005): 410S - 416. [Abstract] [Full Text]

				B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert Omega-3 Polyunsaturated Fatty Acids and Skeletal Health Experimental Biology and Medicine, June 1, 2001; 226(6): 485 - 497. [Abstract] [Full Text] [PDF]

				N. S. Krieger, W. R. Parker, K. M. Alexander, and D. A. Bushinsky Prostaglandins regulate acid-induced cell-mediated bone resorption Am J Physiol Renal Physiol, December 1, 2000; 279(6): F1077 - F1082. [Abstract] [Full Text] [PDF]

				J. Fitzgerald, T. J. Dietz, and M. Hughes-Fulford Prostaglandin E2-Induced Up-Regulation of c-fos Messenger Ribonucleic Acid Is Primarily Mediated by 3',5'-Cyclic Adenosine Monophosphate in MC3T3-E1 Osteoblasts Endocrinology, January 1, 2000; 141(1): 291 - 298. [Abstract] [Full Text] [PDF]

				M. R. Wani, K. Fuller, N. S. Kim, Y. Choi, and T. Chambers Prostaglandin E2 Cooperates with TRANCE in Osteoclast Induction from Hemopoietic Precursors: Synergistic Activation of Differentiation, Cell Spreading, and Fusion Endocrinology, April 1, 1999; 140(4): 1927 - 1935. [Abstract] [Full Text]

				C. S. Lader and A. M. Flanagan Prostaglandin E2, Interleukin 1{alpha}, and Tumor Necrosis Factor-{alpha} Increase Human Osteoclast Formation and Bone Resorption in Vitro Endocrinology, July 1, 1998; 139(7): 3157 - 3164. [Abstract] [Full Text] [PDF]

				T. Wakikawa, A. Shioi, M. Hino, M. Inaba, Y. Nishizawa, N. Tatsumi, H. Morii, and S. Otani Thrombopoietin Inhibits in Vitro Osteoclastogenesis from Murine Bone Marrow Cells Endocrinology, October 1, 1997; 138(10): 4160 - 4166. [Abstract] [Full Text] [PDF]

				Q.-R. Chen, C. Miyaura, S. Higashi, M. Murakami, I. Kudo, S. Saito, T. Hiraide, Y. Shibasaki, and T. Suda Activation of Cytosolic Phospholipase A2 by Platelet-derived Growth Factor Is Essential for Cyclooxygenase-2-dependent Prostaglandin E2 Synthesis in Mouse Osteoblasts Cultured with Interleukin-1 J. Biol. Chem., February 28, 1997; 272(9): 5952 - 5958. [Abstract] [Full Text] [PDF]

				D. Heath Review article : Hypercalcaemia of malignancy Palliative Medicine, January 1, 1989; 3(1): 1 - 11. [Abstract] [PDF]

				D. A. Bushinsky, W. R. Parker, K. M. Alexander, and N. S. Krieger Metabolic, but not respiratory, acidosis increases bone PGE2 levels and calcium release Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1058 - F1066. [Abstract] [Full Text] [PDF]